ATX-101 (Deoxycholic Acid Injection) Treatment in Men: Insights From Our Clinical Experience. (November 2017)

• Record Type: Journal Article
• Authors: Shridharani, Sachin M.; Behr, Kathleen L.
• Is Part Of: Dermatologic surgery. Volume 43(2017)Supplement 2
• Publication Date: 2017-11
• Subjects: Skin -- Surgery -- Periodicals; Skin -- Diseases -- Surgery -- Periodicals; 617.477
• DOI: 10.1097/DSS.0000000000001306
• Languages: English
• ISSNs: 1076-0512

Abstract

Abstract : BACKGROUND: Excess submental fat (SMF), also called a double chin, is an area of concern for men that can be addressed clinically. ATX-101 (deoxycholic acid injection; Kybella in the United States and Belkyra in Canada, Australia, and various European countries) is the first injectable approved for reduction of SMF. OBJECTIVE: To share the authors' clinical experience using ATX-101 in men with submental fullness and offer insights regarding how this treatment may be presented to men as an option to improve their submental profile. METHODS: Retrospective review of the authors' medical records for male patients treated with ATX-101. RESULTS: To allow for fewer ATX-101 treatments, it is recommended that a large surface area be treated at the first session. The positive changes and outcomes achieved with ATX-101 build confidence between the physician and patient, which often leads to male patients seeking other aesthetic treatments to improve their overall appearance. CONCLUSION: ATX-101 treatment is often an effective introduction to aesthetic medicine for men.